Clinical Trial Update: Topotecan in Treating Patients With Recurrent Brain Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating topotecan in patients with recurrent brain tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain and Central Nervous System Tumors

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED